Log in or Sign up for Free to view tailored content for your specialty!
Headache News
Mindfulness intervention reduces impact of migraine on quality of life
Mindfulness-based stress reduction improved disability, quality of life and other measures related to migraine, although it did not reduce frequency more than headache education, according to a study published in JAMA Internal Medicine.
Prednisone demonstrates efficacy as preventive treatment for episodic cluster headache
Oral prednisone led to a greater decrease in the number of episodic cluster headaches within the first week of treatment vs. placebo, according to findings from a multicenter trial published in The Lancet Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Later school start time linked to fewer migraine days in adolescents
Adolescents with migraine who have later school start times have fewer migraines, according to research published in Headache: The Journal of Head and Face Pain.
Q&A: Neurological symptoms of COVID-19 remain an ‘evolving story’
Literature on the neurological manifestations of COVID-19 continues to emerge, as does the medical community’s understanding of how COVID-19 impacts the course of underlying neurological conditions like MS and epilepsy.
Global Burden of Disease study examines prevalence of neurological disorders in US
Noncommunicable neurological disorders resulted in “a large and increasing burden” in the United States, according to a systematic analysis of the Global Burden of Disease study from 2017 that was published in JAMA Neurology.
Remote electric neuromodulation device approval extended to treatment of chronic migraine
The FDA has expanded the approval for Nerivio, a wearable remote electrical neuromodulation device controlled by a smartphone app, to treat chronic migraine in adults aged 18 years and older.
Migraine is ‘vigorous player’ that underlies ischemic stroke in young adults
Any migraine, as well as migraine with aura, demonstrated a strong association with cryptogenic ischemic stroke among adults aged 18 to 49 years, according to the results of a prospective, multicenter case-control study.
AXS-07 demonstrates efficacy against migraine in phase 3 trials
In the phase 3 MOMENTUM and INTERCEPT trials, the investigational migraine drug AXS-07 met its coprimary endpoints of pain freedom and freedom from most bothersome symptom at 2 hours compared with placebo.
Migraine interferes with driving ability, reduces driving frequency
Functional impairments and symptoms related to migraine caused patients to avoid driving, which negatively affected work productivity, according to findings presented at the Annual Meeting of the American Neurological Association.
Adults in LGBTQ community may be at higher risk for migraine
Adults who are gay, lesbian or bisexual, or identify as “mostly heterosexual” were more likely to experience migraine than heterosexual adults, according to research published in JAMA Neurology.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read